J Coates said that ATC "...could be a significant addition to a new class of HIV drugs".http://www.newstatesman.com/healthcare-and-pharmaceuticals/2010/02/hiv-patients-atc-data-avexa
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil